Will You Get to Sit on the Board of Directors as a Startup Investor?

Story originally published here.

When you buy equity in an early-stage startup, you are quite literally buying a piece of that company. That makes you a part owner.

But what does being a “part owner” of a startup really mean? Will you be able to call up the CEO on his cellphone, ask for personal favors, or make recommendations for key hires?

Can you dictate that company’s marketing strategy? Will you be heard when you have concerns to share? Do you even get a vote?

Unless you’re on the board of directors, the answer is probably “no.”

The board of directors is a panel of experts and investors that help manage a startup’s business affairs. The board helps out with everything from appointing chief executives to writing company bylaws and more.

In short, the board of directors comes up with long-term strategies, which the startup’s officers are then obligated to fulfill.

Normally, only the biggest investor in each round ends up with a seat on the board. So, if you invest the minimum amount in a startup alongside someone who throws in a cool million bucks, you aren’t going to be the one sitting at the table when it’s time to pick a CFO or decide whether to offer dividends to shareholders.

If you watch Shark Tank, you may recall that many of the entrepreneurs who pitch to the Sharks actively request that the ones who invest take a seat at the board of directors. That’s because the legendary Shark Tank investors are coveted experts in their field, each with dozens (if not hundreds) of deals under their belts.

That expertise is exactly why I sat down with Shark Tank’s own Robert Herjavec this summer to discuss his winning strategies.

Read the rest of the article here.

To watch the video with Robert Herjavec, click here.

$2 EV Stock No One's Talking About

This company is a sneaky EV play that no one’s talking about. They’re producing an odd variation on the traditional EV that has consumers raving.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$30 Stock Freaking Out Billionaires

This stock is an industry leader in a robotics technology that is freaking out billionaires (trading for just $30).

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The Best TaaS Stock Right Now

This company is set to corner the market in a self-driving technology that  could fundamentally change our entire society – much like the internet did.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Up to 20,000 IPOs All in One Day

A radical $2.1 quadrillion shift is coming to the financial markets.

Some are calling it G.T.E. and Mark Cuban, Elon Musk, Richard Branson, and even banks like J.P. Morgan are invested in the tech behind it.

Just $25 could get you in alongside these billionaires. 

Enter your email address to receive the video that reveals it all.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

53-cent Biotech Stock with $2 Price Target

Steve Cohen, the billionaire stock picker known for running one of the most successful hedge funds ever, has poured millions into the first stock, and it’s trading for only 53 cents.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works